Stocks / KRYS / Shares Outstanding

Krystal Biotech, Inc. Shares Outstanding 2016–2025

Krystal Biotech, Inc. reported 29.2M of shares outstanding for fiscal 2025. That was 1.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +48.1%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.

Latest filed value
29.2M
One-year change
+1.4%
Change since 2020
+48.1%
Latest period end
2025-12-31
Krystal Biotech, Inc. Shares Outstanding history from 2016 to 2025FY 2016: 0FY 2017: 10307247FY 2018: 14428916FY 2019: 17354310FY 2020: 19714220FY 2021: 25207985FY 2022: 25763743FY 2023: 28237000FY 2024: 28794000FY 2025: 29192000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearShares OutstandingChange (YoY)
FY 202529.2M+1.4%
FY 202428.8M+2.0%
FY 202328.2M+9.6%
FY 202225.8M+2.2%
FY 202125.2M+27.9%
FY 202019.7M+13.6%
FY 201917.4M+20.3%
FY 201814.4M+40.0%
FY 201710.3M—
FY 20160.0M—

Source: Krystal Biotech, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open KRYS 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Krystal Biotech, Inc. reported 29.2M of shares outstanding for fiscal 2025. That was 1.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +48.1%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Krystal Biotech, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Krystal Biotech, Inc. — frequently asked questions

What is Krystal Biotech, Inc.'s shares outstanding?

Krystal Biotech, Inc. (KRYS) reported shares outstanding of 29.2M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Krystal Biotech, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.

More KRYS financial history

KRYS revenueKRYS net incomeKRYS gross profitKRYS eps (earnings per share)KRYS ebitdaKRYS free cash flowKRYS total debtKRYS dividend historyKRYS p/e ratio

Full KRYS fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →